1
EXHIBIT 10.43
AGREEMENT
This Agreement (the "Agreement") is made and entered effective as of the 29th
day of January, 1997, by and between AG Associates, Inc., a California
corporation formerly known as AG Processing Technologies, Inc., (hereinafter
"AGA"), and AG Associates (Israel) Ltd., an Israeli company (hereinafter "AGI").
WHEREAS prior to entering into this Agreement, the parties hereto entered into a
certain Agreement dated February 27, 1995 (the "Original Agreement"), by
and among AGA, AGI, Rapro Technology Inc. ("RAPRO"), CLAL Electronics
Industries Ltd.. ("CLAL"), and Arnon Gat ("GAT") pursuant to which,
among other matters, AGA and RAPRO: (a) transferred to AGA and AGI joint
ownership of the technology, owned by AGA and RAPRO, which related to a
chemical vapor deposition cluster tool used in the manufacture of
semiconductors and (b) licensed to AGI additional technology relating to
temperature measurements of rapid thermal processes, used in the
manufacture of semiconductors; and
WHEREAS the parties herein, with the approval of RAPRO, CLAL and GAT, set forth
in a separate document, desire to make amendments to the abovementioned
technology transfer and license provisions in the Original Agreement, as
set forth in this Agreement; and
WHEREAS AGA has developed certain technologies relating to the rapid thermal
processing of semiconductors, which AGI wishes to license from AGA and
AGA has agreed to grant AGI license thereto, all under the terms and
conditions set forth herein;
NOW THEREFORE, in consideration of the mutual representations, warranties,
covenants and conditions contained herein, the parties to this Agreement hereby
agree as follows:
1. PREAMBLE AND ANNEXES
The preamble to this Agreement and all annexes attached hereto form an
integral part of this Agreement.
2
2
2. DEFINITIONS
2.1 Unless otherwise noted herein, all capitalized terms used herein,
shall have the meaning given to such terms in the Original
Agreement.
2.2 The following capitalized terms shall have the respective meaning
ascribed to them hereinbelow:
2.2.1 "Additional Technology" or "AT" means any Intellectual Property
Right relating to the technology described in Annex "2.2" attached
hereto as the technology exists on the date thereof, including,
without limitation, Intellectual Property Rights, with respect to
Documentation and Devices and Components related thereto.
2.2.2 "AT Improvements" means Improvements to the Additional Technology,
that are made, discovered or first reduced to practice, directly or
indirectly, alone or jointly with others from the date hereof, until
June 30, 1998, by either AGA or AGI.
3. AMENDMENTS TO THE ORIGINAL AGREEMENT
Section 5.3.2.4 to the Original Agreement is being hereby replaced by the
following Section 0.0.0.0:
"5.3.2.4 Trademark or Other License Rights. Without additional consideration,
AGA hereby grants AGI a non- transferable license to use the name "AG
Associates," but only in conjunction with the word "Israel", and to use
the AGA trademark (a diagonal set of yellow lines in triangular form),
but only in conjunction with the name "AG Associates Israel", "AG
Israel" or "AGI". However, AGA shall be entitled to terminate such
license by a prior written notice to AGI of not less than 18 (eighteen)
months."
3
3
4. THE ADDITIONAL TECHNOLOGY
4.1 Grant of License
(a) In consideration for the royalty payments set forth in Section
4.2(a) below, AGA hereby grants AGI a perpetual, irrevocable,
worldwide, non-exclusive license, to make, use and distribute
products embodying the Additional Technology, and to modify
and prepare derivative works of, and otherwise use, the
Additional Technology. Subject to Section 4.5 hereto, and
without derogatingtherefrom, such license shall be
non-transferable without the prior written consent of AGA.
(b) At AGI's reasonable request, AGA shall take any action, or
authorize and empower AGI or AGI's designee, including its
attorneys, to take on AGAs behalf, but at AGI's expense, any
action deemed necessary to AGIin order to protect AGA's
Intellectual Property Rights in the Additional Technology.
4.2 Payment of Royalties
(a) In consideration for the license to the Additional Technology,
granted to AGI hereunder, AGI shall pay AGA royalties, as
follows:
(i) for any system module that incorporates both an
axisymmetric heater, which is based on theAdditional
Technology received from AGA (hereinafter: the
"Heater"), and a parallel plate temperature measurement
device based on the Additional Technology received from
AGA (hereinafter. the "Measurement Device") (all
together hereinafter: the "Combined Module") for which
AGI actually receives revenues - US$ 17,000;
(ii) for any system module that incorporates either a Heater
or a Measurement Device (hereinafter: the
4
4
"Non-Combined Module") for which AGI actually receives revenues -US$ 8,500.
It is hereby clarified that AGI's obligation to pay royalties to AGA shall only
be for the sales of Combined Modules or Non-Combined Modules.
Notwithstanding anything to the contrary herein, the aggregate sum of royalties
paid by AGI to AGA shall in no event exceed the total sum of US$ 2,000,000,
whereafter AGI shall be exempted from any obligation to pay royalties.
It in hereby provided that AGI's obligation to pay royalties, as aforesaid,
shall be due only when, and as long as, AGI's annual financial statements
reflect profits stemming from current business activities, and, further
provided, that the sum of royalties paid in any quarter according to subsection
(b) below, shall not exceed 20% of the operating profits for the previous
calendar quarter. It Is hereby clarified that any amount of royalty payments not
paid in accordance with the above, shall be retained on account to be paid in
subsequent quarters, subject to the abovesaid conditions regarding AGI's profits
and the bar of the 20% of operating profits in said quarters as aforesaid.
(b) The royalties provided for in this Section 4.2 (a) shall be paid within
thirty (30) days following the end of each calendar quarter with respect
to sales revenues actually received in the previous quarter. Payment will
be accompanied by a written statement, certified by the Chief Financial or
Executive Officer of AGI stating the number of Combined and non-Combined
Modules sold.
(c) In connection with the payment of royalties, AGA will be entitled, at
AGA's expense, to audit the books and records of AGI in order to verify
the accuracy of the royalties paid. Audits may be conducted by an
Independent CPA at reasonable places during normal business hours, but no
more frequently than once in any particular calendar quarter. The CPA will
undertake not to disclose to AGA and/or any
5
5
third party any confidential information or other valuable commercial
information.
4.3 AT Improvements
Subject to Section 4.5 herein, each of AGI and AGA hereby covenants and
undertakes that all the AT Improvements which are: (a) made. discovered or
first reduced to Practice by AGA, or on its behalf, and are thus licensed
to AGI and (b) made. discovered or first reduced to practice by ACT, or on
its behalf, and thus cross-licensed to AGA, without any additional
consideration. such license or cross-license will be perpetual.
irrevocable. worldwide, non-exclusive and will confer upon the licensee Or
cross-licensee the same rights, granted under Section 4 hereto, with
respect to the Additional Technology, and
All provisions hereunder pertaining to the Additional Technology, except
for the obligation to pay royalties, shall apply, mutatis mutandis, to the
AT improvements.
AGA and AGI will each provide the other with such AT Improvements to be licensed
or cross-licensed, pursuant to the terms herein, within a commercially
reasonable time after such AT Improvements have been made, discovered or first
reduced to practice by such party. AGA and AGI will have the rights that are to
be licensed or cross-licensed, under this Agreement respecting the other party's
AT Improvements, when created. developed or invented, regardless of whether or
not physically delivered to such party.
4.4 Grant of Rights to the Additional Technology
4.4.1 (i) Any sale, transfer or license of the Additional Technology shall
require the prior written consent of AGA.
(ii) Any sale, transfer or license of any of the AT Improvements, by the party
who has a license or cross-license to such AT Improvement, shall require
the prior written consent of the party who developed or made such
improvement.
6
6
4.4.2 It is hereby clarified that:
(i) AGA can sell, transfer or license the Additional
Technology without any limitation; and
(ii) The party who developed or made the AT Improvement can sell, transfer or
license such improvement without any limitation; provided however, that if
such sale or license includes any additional Technology or AT Improvement
developed or made by the other Party, such grant shall require the other
Party's prior written consent.
4.5 Governmental Restrictions
(a) In order to enable AGI to receive funds under the 0.25
Micron Consortium of the Magnet Program (the
"Consortium") managed by the Chief Scientist of the
Ministry of Industry and Commerce ("Chief Scientist"), in
which Consortium AGI is currently a member, AGA hereby
grants its consent to AGI's granting of a license or
sub-license, as applicable, to the CVD Technology and/or
to any CVD Improvements and/or to the RTPT Technology
and/or to any RTPT Improvements and/or to the Additional
Technology and/or to any AT Improvements, to the other
members of the Consortium, all as required under the
agreements of the Consortium; provided however that:
(1) AGI shall receive the prior consent of the members of
the Consortium, and of the Chief Scientist, to the
transfer to AGA of the Improvements made by AGI to the
technologies which originated from AGA, which Improvements
were developed by AGI within the Consortium; and (2) that
the Consortium agreements shall contain a provision,
according to which, upon the purchase of more than 25% of
the share capital or the voting power of any member of the
Consortium by a single non-member, and any of its
affiliates (i.e. any entity controlled by it, or
controlling it or under same controlling parties, if any,
in one transaction or series of related transactions,
7
7
then to the extent that any such non-member or any of its affiliates is a
competitor of any member of the Consortium or might be a competitor of any other
member - such member whose shares or voting power is acquired as aforesaid,
shall be deemed to have retired from the Consortium and its membership shall
expire, unless all of the other Consortium members approve of the purchase; and
(3) that Opal Ltd. and Orbot Instruments Ltd. shall cease to be members of the
Consortium; and (4) that the consortium agreements shall provide adequate
provisions regarding the non-disclosure of the technologies and the non-transfer
of the technologies to non-members.
(b) Notwithstanding anything to the contrary herein or in the Original
Agreement, if AGI submits an application for development of any
technology to the Israeli Chief Scientist under the Law for the
Encouragement of Industrial Research and such application, if granted,
could
(i) prohibit AGI from performing any of its obligations, if any, to deliver
technology to AGA or to license such technology to AGA; or
(ii) require AGI to transfer any rights in, or disclose such technology to any
third party and such transfer or disclosure would constitute a violation
of AGI's obligations under this Agreement or the Original Agreement,
then in either event, AGI must obtain AGA's prior written. consent to submit
such application. If any application is granted by the Israeli Chief Scientist
having the effects described in clause (i) or (ii) above, and AGA's consent ham
not already been obtained to such application prior to submission, then AGI will
not enter into the development described in such application without first
obtaining AGA's written consent. AGA hereby approve its consent to the current
application which AGI have submitted for the approval of the Chief Scientist and
consent that AGI shall submit the application which it stands to submit which
application covers the R&D plans set forth in Annex "4.5" attached hereto, and
agree that the grant of a license to,
8
8
cross-license to, or co-ownership, as applicable, in the Improvements which
shall be made by AGI under the plans covered by said applications shall be
subject to the approval of the Chief Scientist, and shall be granted in
accordance with the terms of such approval, if any. AGI will use diligent,
repeated, good-faith efforts to obtain the approval of the Israeli Chief
Scientist to the delivery and license of technology to AGA and to keeping the
technology confidential in accordance with this Agreement and the Original
Agreement.
4.6 Termination of License
The license granted herein to a Party by the other Party, to the
Additional Technology and/or to any AT Improvement, as applicable, and the
license granted by a Party to the other Party under the Original Agreement
to the RTPT Technology and/or to any RTPT Improvement, as applicable,
shall be terminated and such Party who received such licenses to said
technologies (the "Licensee Party') shall have no rights with respect to
such technologies, in the event the (a) the Licensee makes a general
assignment for the benefit of creditors: or (b) the Licensee files a
voluntary petition of bankruptcy; or (c) a permanent liquidator is
appointed over the Licensee pursuant to a liquidation proceeding against
it; or (d) the Licensee has wound-up or liquidated its business
voluntarily or otherwise.
4.7 Representations by AGA
AGA hereby represents, warrants, covenants and undertakes towards AGI the
following to be true and correct as of the date of execution hereof:
(a) AGA is the sole and exclusive owner of all rights, title and interests
in and to the Additional Technology, and such rights are free and
clear of all liens, adverse claims, security interests or encumbrances
or other third parties rights.
(b) AGA has the full right and authority to grant AGI the license to the
Additional Technology as provided herein.
9
9
Without derogating from that which is stated in clause (a) above, the use of the
Additional Technology by AGI, and the implementation of AGI's rights hereunder,
will not violate or infringe any third party's rights whatsoever.
In the event of a breach of any representation, warranty, covenant or
undertaking set forth in this Section 4.7, AGA shall pay to AGI, as sole and
exclusive pecuniary liability, 50 cents of any US$1 actually paid by AGI to any
third party by reason of such breach (the "Payment Sum"), but in no event shall
AGA's obligation to pay the Payment Sum exceed an amount equal to the aggregate
amount of royalties paid or to be paid by AGI to AGA pursuant to the provisions
herein, whereas the payment of any Payment Sum which exceeds the aggregate
amount of royalties payments already paid to AGA by AGI, shall be made only by
way of set off from future royalties payments coming to AGA from AGI hereunder,
and not by way of actual cash payments.
4.9 Incorporation by Reference
Sections 5.3.6.2 ("CVD Documentation'), 5.3.6.3 ("Improvements
Documentation"), 5.3.8 ("Compliance with Law"), 5.3.11
("Covenant"), 18 ("Governing Law"), 20 ("Expenses and Taxes"), 21
("Confidentiality"), 22 ("Non-Assignability"), 23 ("Execution in
Counterparts"), 24 ("Captions") and 26 ("Further Cooperation") to the
Original Agreement (as amended herein), shall apply, mutatis mutandis,
with respect to the Additional Technology and the AT Improvements.
4.10 It in hereby clarified that the license granted herein to the Additional
Technology and to the AT Improvements, does not permit either Party to be
engaged in the other Party's exclusive field of use, set forth in Annex Y
attached to the Original Agreement and as further clarified in writing, or
derogate in any other way from the Parties' obligations not to be engaged
each in the other's said exclusive field of use during the Non-Compete
Term, and therefore each Party shall continue to be restricted during the
Non-Compete Term from being engaged, including by using the AT
10
10
Technology or the AT improvements, in the other Party's field of use, as set
forth in said Annex Y as further clarified in writing.
5. NOTICES
All notices given by one party to the other hereunder, will be given in
writing, and will be deemed to have been delivered to the addresee
immediately on their delivery if delivered by hand, or upon transmission,
if sent by facsimile, and confirmed by written reply by facsimile, or
within five (5) business days after being sent by mail, express airmail,
or via international courier, as per the addresses indicated hereinbelow,
or to such other address or facsimile number as a party may thereafter
give notice in writing, to the other parties of this Agreement.
If to AGA:
AG Associates, Inc. 0000 Xxxxxxx Xxxxx Xxx Xxxx, Xxxxxxxxxx 00000
U.S.A., Facsimile No. (000) 000-0000, Attention: Chief Executive
Officer.
If to AGI:
AG Associates (Israel) Ltd Industrial Park at Xxxxx Xxxxxxx, X.X.X.
000, Xxxxxx XxXxxx 00000 Xxxxxx, Facsimile No. 06-440551, Attention:
General Manager.
IN WITNESS WHEREOF the parties have signed:
----------------------------
AGA ASSOCIATES, INC. (AGA)
----------------------------------
AG ASSOCIATES (ISRAELI LTD. (AGI)
11
ANNEX 2.2
Following is the specific additional technology ("AT") created by AGA that is
being licensed to AGI by AGA pursuant to the term of this Agreement:
1. Axisymmetric heater assembly comprised of the detailed design and
simulation files for multiple ring with point source vertical filament
lamps. The design includes reflector optimization, spacing and density of
lamps, water-and air cooling manifolds Ids.
2. Reflectivity enhanced temperature measurement subsystem elements which
include the AGA's vendor name for reflective coating, optimization of
fiber rod distance from wafer, software algorithm and simulation files for
temperature measurement spot correction for the AGA's parallel plate
design configuration.
12
ANNEX 4.5 TO THE TECHNOLOGY AGREEMENT
The following program that was submitted by AGI to the chief scientist and was
approved, constitutes improvements to the heater technology as received form
AGA:
Improvements of the axisymetric heater design for higher reliability and ease of
Manufacturability. The program includes CIP (continuous improvement program) and
use of simulation and optimization to improve heater performance based on field
feedback.
